CHOP researchers have found that modifying bioprosthetic heart valves (BHV) with a polymer known as POZ prevents structural degeneration of the valve.

CHOP researchers have found that chemo-resistant mesenchymal cells in neuroblastoma might be vulnerable to immunotherapy.

Children’s Hospital of Philadelphia (CHOP) today announced the completion of its 100th home renovation for families enrolled in the Community Asthma Prevention Plus (CAPP+) Program.

A new study in Nature has documented the longest persistence of CAR T cell therapy to date.

The award from March of Dimes recognizes Dr. Flake’s work, which has advanced the science that underlies our understanding of pregnancy, birth, and prenatal development.

The method could eventually lead to more personalized medicine approaches as well as properly diagnose patients with multiple disorders.

Arunjot Singh, MD, MPH, Co-Director of the Center for Celiac Disease at Children's Hospital of Philadelphia, spoke with Reuters Health about a study that recently appeared in the Archives of Disease in Childhood, which looked at 5-year follow-up of new cases after a celiac disease screening.

Tracey Jubelirer, MD, is the Medical Director of the inpatient oncology unit at the Middleman Family Pavilion at Children’s Hospital of Philadelphia, King of Prussia.

CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.

Method measures motor imitation skills, which have been challenging to measure consistently and precisely.